Physician profile
Pratap Singh
NPI 1417203001
$14,105.31
in general payments reported to CMS, 2019-2025
28 companies · $986 in 2025
The $986 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,725 · 2020: $1,571 · 2021: $348 · 2022: $889 · 2023: $852 · 2024: $735 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,191 · Travel and Lodging: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,191.19 |
| Travel and Lodging | $381.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $8,803.24 | 2019-2020 | |
| Boston Scientific Corporation | $1,657.28 | 2020-2024 | Watchman Access System |
| Biosense Webster, INC. | $618.79 | 2020-2025 | Carto 3 |
| Medtronic, INC. | $601.41 | 2021-2025 | Cardioblate, Affera Mapping System, Linq II |
| Novartis Pharmaceuticals Corporation | $530.81 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $384.23 | 2020-2025 | Lifevest |
| Abbott Laboratories | $376.20 | 2022-2025 | Ensite, Aveir, Cardiomems |
| Philips North America LLC | $248.58 | 2022-2025 | Bridge, (9278) Bridge |
| Pfizer INC. | $130.54 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $93.97 | 2022-2025 | Verquvo |
| Heartflow, INC. | $76.14 | 2021 | |
| Novo Nordisk INC | $62.61 | 2024-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.81 | 2022-2023 | Jardiance |
| Amgen INC. | $59.70 | 2021-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $54.61 | 2021-2023 | Brilinta |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $53.44 | 2023 | Trintellix |
| Janssen Pharmaceuticals, INC | $52.01 | 2021 | |
| Cvrx, INC. | $42.63 | 2023 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $26.35 | 2024 | Arcalyst |
| Janssen Biotech, INC. | $26.16 | 2024 | Tremfya |
| Inspire Medical Systems, INC. | $24.87 | 2025 | Inspire |
| Atricure, INC. | $24.58 | 2024 | |
| Cardiva Medical, INC. | $20.63 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bayer Healthcare Pharmaceuticals INC. | $19.13 | 2025 | |
| Zoll Circulation INC | $14.65 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| E.R. Squibb & Sons, L.L.C. | $14.59 | 2024 | Camzyos |
| Kestra Medical Technology Services, INC. | $13.37 | 2023 | Assure Wcd |
| Convatec INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratap Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.